Home State: Oregon

State: Oregon

Oregon Business News, Entertainment, and Technology News (U.S.)

New Infographic, Finding Mold in a New Home, Illustrates How to Check for Mold Before It’s Too Late

eNewsChannels NEWS: -- Mold Inspection Sciences (MIS), one of the state's largest mold inspection and testing companies, has announced the publication of an infographic now available to view and download from the Mold Inspection Sciences website.

Paragon BioTeck announces Alejandro Arboleda Named 2018 Koch Kellan Scholar

eNewsChannels NEWS: -- Paragon BioTeck, Inc., an ophthalmic pharmaceutical and medical device company, announced today that Alejandro Arboleda has been named its 2018 Koch Kellan Scholar. Paragon Gives, a Paragon BioTeck initiative, awards the Koch Kellan Scholarship to an outstanding graduate medical student committed to elevating the standard of eye care through social responsibility and a clinical, teaching or research career in ophthalmology.

XG Communities awarded an exclusive wireless marketing agreement with the City of Portland Oregon

eNewsChannels NEWS: -- XG Communities, a premier provider of wireless marketing plans and engineering services for cities and municipalities across the United States, has been awarded an exclusive wireless marketing agreement with the City of Portland.
Xinxin Zhang

Paragon Gives announces Ms. Xinxin Zhang Named 2017 Koch Kellan Scholar

eNewsChannels NEWS: (PORTLAND, Ore.) -- Paragon BioTeck, Inc., an ophthalmic pharmaceutical and device company, announced today that Xinxin Zhang has been named its 2017 Koch Kellan Scholar. Paragon Gives, a Paragon BioTeck initiative, awards the Koch Kellan Scholarship to an outstanding graduate medical student committed to pursuing a clinical, teaching or research career in ophthalmology.
Paragon BioTeck Inc

Ruling by USPTO Affirms Patent Claim for Paragon BioTeck’s R-Phenylephrine Hydrochloride Formulation

eNewsChannels NEWS: (PORTLAND, Ore.,) -- Paragon BioTeck, Inc. announces a monumental ruling handed down by the United States Patent and Trademark Office (USPTO) affirming claims made by Paragon in the patent for its R-phenylephrine hydrochloride formulation. Paragon is a privately held pharmaceutical and medical device company specializing in the development and commercialization of ophthalmic pharmaceuticals, devices and therapies.
Paragon BioTeck Inc

Paragon BioTeck, Inc. Announces its 2017 Koch Kellan Scholarship

NEWS (PORTLAND, Ore.) -- Paragon BioTeck, Inc., a privately held pharmaceutical and medical device company, announced today a call for applications for the 2017 Koch Kellan Scholarship, awarded annually to an outstanding graduate medical student committed to pursuing a clinical, teaching or research career in ophthalmology. A Paragon Gives initiative, the Koch Kellan Scholarship reinforces the fundamental mission of Paragon BioTeck to drive innovations to address unmet and underserved medical needs and improve the quality of lives around the world.

Mr. Hasenin Al-khersan Named 2016 Koch Kellan Scholar by Paragon BioTeck

NEWS: (PORTLAND, Ore.) Paragon BioTeck, Inc., announced today that Hasenin Al-khersan has been named its 2016 Koch Kellan Scholar. Paragon Gives, a Paragon BioTeck initiative, awards the Koch Kellan Scholarship to an outstanding graduate medical student committed to pursuing a clinical, teaching or research career in ophthalmology.

Pharma and medical device company, Paragon BioTeck receives EN ISO 13485:2012 Certification

NEWS: (PORTLAND, Ore.) Paragon BioTeck, Inc., a privately held pharmaceutical and medical device company, announced today that it has received EN ISO 13485:2012 certification, signifying the company's successful implementation of an effective quality management system.

Environmental Activist Erin Brockovich and Weitz & Luxenberg Tackle Air Quality Issues in Portland

NEWS: (PORTLAND, Ore.) Long-time environmental activist Erin Brockovich is joining with Weitz and Luxenberg, P.C., attorney Robin Greenwald to investigate claims from Portland, Oregon area residents who may have been harmed by chemical emissions released into the air by art-glass companies in the region.

At 34th Annual J.P. Morgan Healthcare Conference, Paragon BioTeck to sponsor reception held by Oregon Bioscience Assoc.

NEWS: Paragon BioTeck, Inc., a privately held pharmaceutical and medical device company, will sponsor a special reception during the J.P. Morgan 2016 Healthcare Conference, being held in San Francisco, Jan. 11-14. The conference, which is now in its 34th year, is an invitation-only event intended to create an environment of collaboration by bringing together stakeholders in the corporate, investor and financial sectors to learn about and explore market and sector trends.

Huamei Hospital Founder Dr. Edward Reed Wagner Honored in China

NEWS: Dr. Craig Wagner Shinn announces that his great grandfather Dr. Edward Reed Wagner, a missionary doctor in the American Board of Commissioners of Foreign Missions (Global Ministries) in the late 19th century, was honored for founding Huamei Hospital in Linqing, Shandong, China at a special ceremony celebrating the hospital's 130th year on November 1st.

New Children’s Book is Designed to Delight Parents, Typically Developing Kids, and those with ADD/ADHD or Autism Spectrum

PORTLAND, Ore. /eNewsChannels/ -- NEWS: Journey Books, LLC, today announced release of 'Going to Bed is Easy Now' (ISBN: 978-0692357842), first in series of illustrated children's books by Doris and Maritsa Bowman. Written in both English and Spanish editions, the book is designed to ease the stress of everyday activities that create chronically challenging behaviors in typically developing children.

Ophthalmic Pharmaceuticals Company Paragon BioTeck Receives CE Mark Approval on Comfortear Lacrisolve Absorbable Punctum Plug

PORTLAND, Ore. /eNewsChannels/ -- NEWS: Paragon BioTeck, Inc., a privately held biopharmaceutical and medical device company specializing in the development of ophthalmic pharmaceuticals, devices and therapies, announced today that it has received CE mark approval for the recently FDA cleared Comfortear Lacrisolve Absorbable Punctum Plug. CE mark approval is recognized and associated with safety and performance in multiple countries.

Paragon BioTeck, Inc. ormally launching its corporate citizenship initiative coined, Paragon Gives

PORTLAND, Ore. /eNewsChannels/ -- NEWS: Paragon BioTeck, Inc., a privately held biopharmaceutical and medical device company specializing in the development of ophthalmic pharmaceuticals, devices and therapies, announces that it will be formally launching its corporate citizenship initiative coined, Paragon Gives. On Sunday October 19, 2014, Paragon BioTeck, will kick off its newly branded corporate social responsibility initiative at the annual American Academy of Ophthalmology conference in Chicago.

American Academy of Ophthalmology Annual Meeting 2014 to include exhibit from Paragon BioTeck, Inc.

PORTLAND, Ore. /eNewsChannels/ -- NEWS: Paragon BioTeck, Inc., a privately held biopharmaceutical and medical device company specializing in the development of ophthalmic pharmaceuticals, devices and therapies, will be exhibiting at the American Academy of Ophthalmology (Booth #4550) in Chicago on October 18-21, 2014.

Paragon BioTeck Receives 510(k) clearance from the Food and Drug Administration for its Comfortear Lacrisolve Absorbable Punctum Plug

PORTLAND, Ore. /eNewsChannels/ -- NEWS: Oregon's Paragon BioTeck, Inc., a privately held biopharmaceutical and medical device company specializing in the development of ophthalmic pharmaceuticals, devices and therapies, announced today it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Comfortear(R) Lacrisolve(TM) Absorbable Punctum Plug.

Paragon BioTeck's FDA Approved Phenylephrine Hydrochloride Ophthalmic Solution Readily Available through Bausch + Lomb

PORTLAND, Ore. /eNewsChannels/ -- NEWS: Paragon BioTeck, Inc., a privately held U.S. biopharmaceutical company specializing in the development of ophthalmic pharmaceuticals and therapies, announces its FDA approved Phenylephrine Hydrochloride Ophthalmic Solution, USP 2.5 percent and 10 percent, to dilate the pupil, is readily available through Bausch + Lomb.

Paragon BioTeck, Inc. receives FDA Approval for Phenylephrine Hydrochloride Ophthalmic Solution, USP 2.5 percent and 10 percent

PORTLAND, Ore. /eNewsChannels/ -- NEWS: Paragon BioTeck, Inc., a privately held biopharmaceutical company specializing in the development of ophthalmic pharmaceuticals and therapies, received FDA approval of Phenylephrine Hydrochloride Ophthalmic Solution, USP 2.5 percent and 10 percent, to dilate the pupil on March 21, 2013.

Paragon BioTeck to launch new line of eyecare products at the Annual American Academy of Ophthalmology meeting

PORTLAND, Ore. /eNewsChannels/ -- NEWS: Biopharmaceutical company Paragon BioTeck, Inc. today announced that it plans to launch its new line of products, known as Ilast(R), at the Annual American Academy of Ophthalmology meeting in New Orleans. Paragon signed an exclusive distribution agreement with Horus Pharma to supply Ilast(R) ocular care products in the U.S. last month, and the company is excited to release these products to ophthalmology professionals.

Paragon BioTeck Inc to Distribute Horus Pharma Ilast Ocular Hygiene in U.S. with Exclusive Agreement

PORTLAND, Ore. /eNewsChannels/ -- NEWS: Paragon BioTeck, Inc. signs a distribution agreement with Horus Pharma for rights to supply the Ilast range of its medical-grade ocular hygiene and lid care products within the United States. It begins on an exclusive basis this month.

Partners for a Hunger-Free Oregon announce Grants Available to Help Feed Kids in Afterschool Settings

PORTLAND, Ore. /eNewsChannels/ -- Partners for a Hunger-Free Oregon is excited to announce a new partnership with the Oregon Department of Education (ODE) to distribute grants to afterschool programs to help feed more kids in Oregon.

Noble Vision Group, has added the revolutionary plug-in, Treato

TIGARD, Ore. /eNewsChannels/ -- Paragon BioTeck, Inc., a research and development organization in the eye care industry, today announced that the company's online community discussion forum and blog, Noble Vision Group, has added the revolutionary plug-in, Treato.

LadyBoss LLC announces the release of LadyBoss-Amanishakhete's new single: Murder 2012

PORTLAND, Ore. /eNewsChannels/ -- The Trayvon Martin murder may have grabbed national headlines over the course of 45 days, but it appears to have died down despite racial profiling and stand-your-ground, taunting black males daily. This travesty amid today's hate-based politics inspires the release of LadyBoss-Amanishakhete's (A-ma-ni-sha-kete) new single: 'Murder 2012.'

Evolve Security today announced a distribution partnership with Smartvue, a leading manufacturer of IP video surveillance solutions

PORTLAND, Ore. /eNewsChannels/ -- Evolve Security, an IP-focused security distributor based in Portland, Oregon, today announced a distribution partnership with Smartvue, a leading manufacturer of IP video surveillance solutions.

ClanGistics announces the launch of their ClanGistics Planning System

PORTLAND, Ore. /eNewsChannels/ -- ClanGistics(TM) announces the launch of their ClanGistics.com website which includes a first time ever e-product called the ClanGistics Planning System(TM). The planning system utilizes secured 'cloud' server technology and data file encryption allowing users to login through a secured web portal and enter personal information safely and securely for instant access in cases of medical or family emergencies.

FEATURED NEWS

WHAT'S NEWS

FROM THE ARCHIVES